Expression of Concern: NF-κB and CREB Are Required for Angiotensin II Type 1 Receptor Upregulation in Neurons (PLoS ONE (2013) 8:11 (e78695) DOI: 10.1371/journal.pone.0078695);NF-κB and CREB are required for angiotensin II type 1 receptor upregulation in neurons

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Haack, Karla K V ^a   Mitra, Amit K ^a   Zucker, Irving H ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 TYPE 1 RECEPTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE I; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; SERINE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR ELK 1; UNCLASSIFIED DRUG; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CREB1 PROTEIN, HUMAN; ELK1 PROTEIN, HUMAN; IMIDAZOLE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PYRIDINE DERIVATIVE; VASOCONSTRICTOR AGENT;

ARTICLE; AT1R GENE; CATECHOLAMINE NERVE CELL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA BINDING; GEL MOBILITY SHIFT ASSAY; GENE; GENE EXPRESSION; GENE SILENCING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; BIOSYNTHESIS; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; UPREGULATION;

ANGIOTENSIN II; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ETS-DOMAIN PROTEIN ELK-1; HUMANS; IMIDAZOLES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; RECEPTOR, ANGIOTENSIN, TYPE 1; UP-REGULATION; VASOCONSTRICTOR AGENTS;

EID: 84892908375     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0294092     Document Type: Erratum

References (43)

1. Steckelings U, Lebrun C, Qadri F, Veltmar A, Unger T (1992) Role of brain angiotensin in cardiovascular regulation. J Cardiovasc Pharmacol 19 Suppl 6: S72-79.
2. Zucker IH, Schultz HD, Patel KP, Wang W, Gao L (2009) Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure. Am J Physiol Heart Circ Physiol 297: H1557-1566.
3. Gao L, Wang WZ, Wang W, Zucker IH (2008) Imbalance of angiotensin type 1 receptor and angiotensin II type 2 receptor in the rostral ventrolateral medulla: potential mechanism for sympathetic overactivity in heart failure. Hypertension 52: 708-714.
4. Li J, Brasier AR (1996) Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes. Mol Endocrinol 10: 252-264.
5. Blume A, Herdegen T, Unger T (1999) Angiotensin peptides and inducible transcription factors. J Mol Med (Berl) 77: 339-357. (Pubitemid 29144070)
6. Gaborik Z, Jagadeesh G, Zhang M, Spat A, Catt KJ, et al. (2003) The role of a conserved region of the second intracellular loop in AT1 angiotensin receptor activation and signaling. Endocrinology 144: 2220-2228. (Pubitemid 36629870)
7. Mitra AK, Gao L, Zucker IH (2010) Angiotensin II-induced upregulation of AT(1) receptor expression: sequential activation of NF-kappaB and Elk-1 in neurons. Am J Physiol Cell Physiol 299: C561-569.
8. Liu D, Gao L, Roy SK, Cornish KG, Zucker IH (2006) Neuronal angiotensin II type 1 receptor upregulation in heart failure: activation of activator protein 1 and Jun N-terminal kinase. Circ Res 99: 1004-1011. (Pubitemid 44657804)
9. Ju H, Behm DJ, Nerurkar S, Eybye ME, Haimbach RE, et al. (2003) p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 1. p38 MAPK-dependent endothelial dysfunction and hypertension. J Pharmacol Exp Ther 307: 932-938. (Pubitemid 37494209)
10. Yoshimoto T, Gochou N, Fukai N, Sugiyama T, Shichiri M, et al. (2005) Adrenomedullin inhibits angiotensin II-induced oxidative stress and gene expression in rat endothelial cells. Hypertens Res 28: 165-172. (Pubitemid 40663068)
11. Funakoshi Y, Ichiki T, Takeda K, Tokuno T, Iino N, et al. (2002) Critical role of cAMP-response element-binding protein for angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem 277: 18710-18717. (Pubitemid 34952428)
12. Xu Q, Liu Y, Gorospe M, Udelsman R, Holbrook NJ (1996) Acute hypertension activates mitogen-activated protein kinases in arterial wall. J Clin Invest 97: 508-514. (Pubitemid 26039417)
13. Sheng M, Thompson MA, Greenberg ME (1991) CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 252: 1427-1430. (Pubitemid 21917061)
14. Xing J, Ginty DD, Greenberg ME (1996) Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273: 959-963. (Pubitemid 26275173)
15. Stakkestad O, Larsen AC, Kvissel AK, Eikvar S, Orstavik S, et al. (2011) Protein kinase A type I activates a CRE-element more efficiently than protein kinase A type II regardless of C subunit isoform. BMC Biochem 12: 7.
16. Tan Y, Rouse J, Zhang A, Cariati S, Cohen P, et al. (1996) FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J 15: 4629-4642. (Pubitemid 26294581)
17. Cardinaux JR, Notis JC, Zhang Q, Vo N, Craig JC, et al. (2000) Recruitment of CREB binding protein is sufficient for CREB-mediated gene activation. Mol Cell Biol 20: 1546-1552. (Pubitemid 30100174)
18. Cammarota M, Paratcha G, Bevilaqua LR, Levi de Stein M, Lopez M, et al. (1999) Cyclic AMP-responsive element binding protein in brain mitochondria. J Neurochem 72: 2272-2277. (Pubitemid 29242176)
19. Lee J, Kim CH, Simon DK, Aminova LR, Andreyev AY, et al. (2005) Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survival. J Biol Chem 280: 40398-40401. (Pubitemid 41780525)
20. Spooren A, Kooijman R, Lintermans B, Van Craenenbroeck K, Vermeulen L, et al. (2010) Cooperation of NFkappaB and CREB to induce synergistic IL-6 expression in astrocytes. Cell Signal 22: 871-881.
21. Walker WH, Fucci L, Habener JF (1995) Expression of the gene encoding transcription factor cyclic adenosine 39,5 9-monophosphate (cAMP) response element-binding protein (CREB): regulation by follicle-stimulating hormone-induced cAMP signaling in primary rat Sertoli cells. Endocrinology 136: 3534-3545.
22. Stein B, Cogswell PC, Baldwin AS, Jr. (1993) Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction. Mol Cell Biol 13: 3964-3974. (Pubitemid 23187624)
23. McKay LI, Cidlowski JA (2000) CBP (CREB binding protein) integrates NFkappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism. Mol Endocrinol 14: 1222-1234. (Pubitemid 32260483)
24. Haack KK, Engler CW, Papoutsi E, Pipinos, II, Patel KP, et al. (2012) Parallel changes in neuronal AT1R and GRK5 expression following exercise training in heart failure. Hypertension 60: 354-361.
25. Baeuerle PA (1991) The inducible transcription activator NF-kappa B: regulation by distinct protein subunits. Biochim Biophys Acta 1072: 63-80.
26. Wang WZ, Gao L, Wang HJ, Zucker IH, Wang W (2008) Interaction between cardiac sympathetic afferent reflex and chemoreflex is mediated by the NTS AT1 receptors in heart failure. Am J Physiol Heart Circ Physiol 295: H1216-H1226.
27. Liu D, Gao L, Roy SK, Cornish KG, Zucker IH (2008) Role of oxidant stress on AT1 receptor expression in neurons of rabbits with heart failure and in cultured neurons. Circ Res 103: 186-193.
28. Schmeisser A, Soehnlein O, Illmer T, Lorenz HM, Eskafi S, et al. (2004) ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression. Biochem Biophys Res Commun 325: 532-540. (Pubitemid 39458027)
29. La Porta CA, Comolli R (1998) PKC-dependent modulation of IkB alpha-NFkB pathway in low metastatic B16F1 murine melanoma cells and in highly metastatic BL6 cells. Anticancer Res 18: 2591-2597. (Pubitemid 28386555)
30. Fan J, Zeller K, Chen YC, Watkins T, Barnes KC, et al. (2010) Time-dependent c-Myc transactomes mapped by Array-based nuclear run-on reveal transcriptional modules in human B cells. PLoS One 5: e9691.
31. Ganea D, Delgado M (2003) The neuropeptides VIP/PACAP and T cells: inhibitors or activators? Curr Pharm Des 9: 997-1004. (Pubitemid 36443201)
32. Ginty DD, Kornhauser JM, Thompson MA, Bading H, Mayo KE, et al. (1993) Regulation of CREB phosphorylation in the suprachiasmatic nucleus by light and a circadian clock. Science 260: 238-241. (Pubitemid 23140894)
33. Frank DA, Greenberg ME (1994) CREB: a mediator of long-term memory from mollusks to mammals. Cell 79: 5-8. (Pubitemid 24309507)
34. Ushio-Fukai M, Alexander RW, Akers M, Griendling KK (1998) p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 273: 15022-15029. (Pubitemid 28272796)
35. Deak M, Clifton AD, Lucocq LM, Alessi DR (1998) Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J 17: 4426-4441. (Pubitemid 28362632)
36. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, et al. (1998) Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 273: 8890-8896. (Pubitemid 28176171)
37. Stein B, Baldwin AS Jr, Ballard DW, Greene WC, Angel P, et al. (1993) Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J 12: 3879-3891. (Pubitemid 23282764)
38. Karin M, Takahashi T, Kapahi P, Delhase M, Chen Y, et al. (2001) Oxidative stress and gene expression: the AP-1 and NF-kappaB connections. Biofactors 15: 87-89. (Pubitemid 34455067)
39. Stefano L, Al Sarraj J, Rossler OG, Vinson C, Thiel G (2006) Up-regulation of tyrosine hydroxylase gene transcription by tetradecanoylphorbol acetate is mediated by the transcription factors Ets-like protein-1 (Elk-1) and Egr-1. J Neurochem 97: 92-104.
40. Swanson DJ, Zellmer E, Lewis EJ (1998) AP1 proteins mediate the cAMP response of the dopamine beta-hydroxylase gene. J Biol Chem 273: 24065-24074. (Pubitemid 28435749)
41. Coven E, Ni Y, Widnell KL, Chen J, Walker WH, et al. (1998) Cell type-specific regulation of CREB gene expression: mutational analysis of CREB promoter activity. J Neurochem 71: 1865-1874. (Pubitemid 28491541)
42. Thiel G, Al Sarraj J, Vinson C, Stefano L, Bach K (2005) Role of basic region leucine zipper transcription factors cyclic AMP response element binding protein (CREB), CREB2, activating transcription factor 2 and CAAT/enhancer binding protein alpha in cyclic AMP response element-mediated transcription. J Neurochem 92: 321-336. (Pubitemid 40194023)
43. Widnell KL, Chen JS, Iredale PA, Walker WH, Duman RS, et al. (1996) Transcriptional regulation of CREB (cyclic AMP response element-binding protein) expression in CATH.a cells. J Neurochem 66: 1770-1773. (Pubitemid 26090582)